DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,470,489 | -6.6% | 5,927 | -9.6% | 0.45% | +0.9% |
Q2 2023 | $1,574,400 | -0.5% | 6,560 | +4.5% | 0.45% | -12.9% |
Q1 2023 | $1,582,307 | -10.6% | 6,278 | -5.9% | 0.51% | -15.8% |
Q4 2022 | $1,770,086 | +0.1% | 6,669 | -2.6% | 0.61% | +20.6% |
Q3 2022 | $1,768,000 | -8.1% | 6,844 | -9.8% | 0.50% | +0.8% |
Q2 2022 | $1,923,000 | -3.0% | 7,584 | +12.2% | 0.50% | +17.3% |
Q1 2022 | $1,983,000 | -7.5% | 6,759 | +3.7% | 0.43% | -9.7% |
Q4 2021 | $2,144,000 | +9.6% | 6,516 | +1.4% | 0.47% | -6.2% |
Q3 2021 | $1,956,000 | +10.8% | 6,426 | -2.3% | 0.50% | +8.6% |
Q2 2021 | $1,765,000 | +25.2% | 6,576 | +4.9% | 0.46% | +19.3% |
Q1 2021 | $1,410,000 | +21.1% | 6,266 | +19.6% | 0.39% | +8.4% |
Q4 2020 | $1,164,000 | +0.4% | 5,238 | -2.7% | 0.36% | -10.7% |
Q3 2020 | $1,159,000 | +21.2% | 5,384 | -0.4% | 0.40% | +11.4% |
Q2 2020 | $956,000 | +20.6% | 5,404 | -5.6% | 0.36% | +0.8% |
Q1 2020 | $793,000 | -8.9% | 5,726 | +1.0% | 0.36% | +11.2% |
Q4 2019 | $870,000 | +0.2% | 5,671 | -5.7% | 0.32% | -7.2% |
Q3 2019 | $868,000 | +0.6% | 6,012 | -0.4% | 0.35% | -3.6% |
Q2 2019 | $863,000 | +12.8% | 6,035 | +4.1% | 0.36% | +13.9% |
Q1 2019 | $765,000 | +42.5% | 5,797 | +11.3% | 0.32% | +22.5% |
Q4 2018 | $537,000 | 0.0% | 5,208 | +5.4% | 0.26% | +18.9% |
Q3 2018 | $537,000 | +13.3% | 4,939 | +2.9% | 0.22% | +9.0% |
Q2 2018 | $474,000 | +0.9% | 4,799 | -0.0% | 0.20% | -0.5% |
Q1 2018 | $470,000 | +4.7% | 4,801 | -0.7% | 0.20% | +3.6% |
Q4 2017 | $449,000 | +30.1% | 4,834 | +20.3% | 0.19% | +25.3% |
Q3 2017 | $345,000 | -4.7% | 4,019 | -6.3% | 0.15% | -9.4% |
Q2 2017 | $362,000 | +3.7% | 4,287 | +5.0% | 0.17% | -7.1% |
Q1 2017 | $349,000 | -9.8% | 4,084 | -17.8% | 0.18% | -13.3% |
Q4 2016 | $387,000 | -2.8% | 4,968 | -2.2% | 0.21% | -9.1% |
Q3 2016 | $398,000 | -32.2% | 5,078 | -12.7% | 0.23% | -39.7% |
Q2 2016 | $587,000 | +7.7% | 5,814 | +1.1% | 0.38% | -0.5% |
Q1 2016 | $545,000 | +10.8% | 5,748 | +1.1% | 0.39% | -20.7% |
Q4 2015 | $492,000 | – | 5,683 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |